Combination of the parent analogue of remdesivir (gs-441524) and molnupiravir results in a markedly potent antiviral effect in sars-cov-2 infected syrian hamsters

HIGHLIGHTS

• who: Remdesivir et al. from the Jackson State University, United States have published the article: Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters, in the Journal: (JOURNAL)
• what: Infectious viruses were first isolated by passaging on Vero E6 cells then passage two virus stocks of the beta variant and the BA.5 variant on Vero E6 and Calu-3 cells, respectively, were used for the studies described here.
• how: Live virus-related work was conducted in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.